Please, download the following pdf files to get the latest version of Scientific programme:
8.00 – 14.30 Clinical Nutrition Workshop (BIG HALL)
Objectives:
- Increase knowledge of standards of practice for clinicians/nutritionists providing care to children with cancer.
- Develop local standards of care with regards to nutritional assessment and support
- Provide tutorial on best-of-care for nutrition intervention among centers with limited resources
- Identify research collaborations between countries for conduct through SIOP PODC committee.
Co-Chairs:
Brijesh Arora (India)
Elena Ladas (USA)
Svetlana Varfolomeeva (Russia)
Paul Rogers (Canada)
8.00 – 8.30 Opening remarks – Brijesh Arora (India), Elena Ladas (USA)
8.30 – 9.15 Overview of the Science: Nutritional Status, Toxicity, Outcome in HIC – Elena J Ladas (USA)
9.15 – 10.00 Nutritional Considerations in Childhood Cancer Survivors – Brijesh Arora (India)
10.00 – 10.30 Nutritional Status and Chemotherapy Administration – Paul Rogers (Canada)
10.30 – 11.00 Break
11.00 – 11.30 Nutritional Interventions-Algorithms, Enteral & Parenteral Nutrition in Pediatric Oncology – Elena J Ladas (USA)
11.30 – 11.45 Organization of nutrition support in pediatric oncology center (160) – the Russian experience – A. Vashura, D. Litvinov (Russia)
11.45 – 12.15 Adaptation of Nutritional Guidelines in LMICs – Brijesh Arora (India)
12.15 – 12.30 Features of enteral nutrition and anorexia overcoming in hematopoietic stem cell transplantation in children (223) – M. Kucher (Russia)
12.30 – 12.45 Results of screening study of nutrition status in oncopediatric clinic (161) – Ekaterina Vasilyeva, Andrey Vashura, Svetlana Lukina, Dmitry Litvinov(Russia)
12.45 – 13.00 Discussion
13.00 – 13.30 Break
13.30 – 14.00 Case report presentations, discussion – A. Vashura, D. Litvinov, I. Zacharov (Russia)
- Case 1: Patient with Gastrostoma feeding
- Case 2: Patient after HSCT
14.00 – 14.30 Discussion and closing remarks
Surgery mentorship (in Dmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology)
Chairs:
Devendra Gupta (India)
Zacharias Zachariou (Cyprus)
Alexander Razumovsky (Russia)
Igor Reshetov (Russia)
Nikolay Grachev (Russia)
Igor Kirgizov (Russia)
Pavel Pryanikov (Russia)
Sergey Talipov (Russia)
Schedule:
8.00 – 8.15 Presentation of patients
8.15 – 12.30 Surgery:
Operating room 1: Head&Neck surgery
Operating room 2: Toraco-abdominal surgery
12.30 – 13.00 Stand simulation (Pathology department)
13.00 – 13.30 Break
13.30 – 14.30 Discussion on performed surgery
15.00 – 16.30 Satellite Symposium: Modern aspects of methods of radiation diagnostics in pediatric oncology
Sponsor: GE Healthcare
Chair: Valentin Sinitsyn (Russia)
15.00 – 15.10 Open remarks - Valentin Sinitsyn (Russia)
15.10 – 15.30 Indications on computer tomography usage in pediatric oncology, decreasing of radiation-absorbed dose and safety of contrast medications. Will it allows to widen the method application? – Natalia Ilina (Russia)
15.30 – 15.50 Magnetic resonance imaging in pediatric oncology – possibilities and limitations of the method – Anatoly Anikin (Russia)
15.50 – 16.10 Apllication of positron emission tomography with Fluorodeoxyglucose in pediatric oncology – Elena Gromova (Russia)
16.10 – 16.30 Modern technologies in ultrasonic diagnostics in pediatrics and neonatology – Anna Oleynichuk (Russia)
Opening Ceremony (BIG HALL)
16.00 – 16.05 Opening speech – Alexander Rumyantsev (Russia)
16.05 – 16.10Russian Government representative speech (Russia)
16.10 – 16.15 Welcoming from the Russian Ministry of Health – Veronika Skvortsova (Russia)
16.15 – 16.20 Salutation from WHO – Oleg Chestnov (Switzerland)
16.20 – 16.25 SIOP Board welcoming speech – Paul Rogers (Canada)
16.25 – 16.30 SIOP Asia President Salutation – Chi-Kong Li (Hong Kong S.A.R.)
16.35 – 16.40 UICC Welcome speech – Tezer Kutluk (Turkey)
16.40 – 16.45 CCI Welcoming speech – Carmen Auste (Philippines)
16.45 – 16.55 Survivors
16.55 – 17.00 A special song presentation from CCI – child4child
8.00 – 9.45 Plenary session: Acute lymphoblastic leukaemia
Chairs: Chi-Kong Li, Guenter Henze
8.00 – 8.15 Acute lymphoblastic leukemia treatment strategies – the Asian experience – Chi-Kong Li (Hong-Kong S.A.R.)
8.15 – 8.30 Acute lymphoblastic leukemia treatment: past, present, future – Guenter Henze (Germany)
8.30 – 8.45 Acute lymphoblastic leukemia treatment in Russia: the unique experience – Alexander Karachunsky (Russia)
8.45 – 9.00 Evolution of Acute lymphoblastic leukemia treatment in United States – Paul S. Gaynon (USA)
9.00 – 9.15 Acute lymphoblastic leukemia at Adolescents and Young Adults – Paul Rogers (Canada)
9.15 – 9.45 Discussion
10.00 – 11.30 Satellite symposium: Infection complications at immune compromised patients
Sponsor: Pfizer
Chair: Galina Novichkova (Russia)
10.00 – 10.50 Diagnosing and treatment of invasive aspergillosis – A. Groll (Germany)
10.50 – 11.10 Possibilities of bronco-alveolar lavage in diagnosing of invasive aspergillosis – Alisa Volkova (Russia)
11.10 – 11.30 Complex approach to infection control on clinic – Galina Solopova (Russia)
10.00 – 11.30 Parallelsession: Acute lymphoblastic leukaemia
Chairs: Paul Rogers, Alexander Karachunsky
10.00 – 10.10 Gene expression-based classification and risk stratification of pediatric acute lymphoblastic leukemia (291) – Sun Yanran, Zhang Han, Cheng Hao, Gao Chao, Wang Qingqing, Han Jingdong, Zheng Huyong (China)
10.10 – 10.20 Outcome of Paediatric Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ ALL) Using Aggressive Chemotherapy with Imatinib in India (324) – Brijesh Arora, Kalasekhar Vijayasekharan, Nirav Thackar, Gaurav Narula, Nikhil Patkar, Sumit Gujral, Prashant Tembhare, Mani Subramaniam, Prathibha Amre Kadam, Shripad Banavali (India)
10.20 – 10.30 Impact of cytogenetic evolution on outcome of allogeneic hematopoietic stem cell transplantation at posttransplant relapses in pediatric acute leukemia patients (098) – Tatiana L Gindina, Nikolay Mamaev, Elena Nikolaeva, Olga Slesarchuk, Kirill Ekushov, Olesya Paina, Anastasya Borovkova, Lyudmila Zubarovskaya, Boris Afanasyev (Russia)
10.30 – 10.40 Comparison Between UKALL and Lahore Protocol on Induction Response in Pre B, Acute Lymphoblastic Lymphoma (326) – Safia Khan, Saadia Anwar (Pakistan)Characteristics and outcome of 10.40 – 10.50 MLL gene re- arrangement positive pediatric Acute Lymphoblastic Leukemia: a report on 371 cases (079) – Suleimman Ahmad Al-sweedan, Rafat Jafri, Khawar Siddiqui, Ali Alahmary, Ibrahim Ghemlaz, Naemah Farhan, Amal Al-Seraihi (Saudi Arabia)
10.50 – 11.00 Evaluation of risk factors and patterns of CNS complications in childhood hematological malignancies during early phase of treatment (386) – Zannat Ara, Chowdhury Yakub Jamal, Afiqul Islam, Md Anwarul Karim, ATM Atikur Rahman, Momena Begum, Mehnaz Akter, Lutfor Rahman (Bangladesh)
11.00 – 11.30 Discussion
10.00 – 11.30 Parallel session: Surgery 1
Chairs: Zacharias Zachariou, Igor Kirgizov
10.00 – 10.20 Modern surgical strategies in oncology – Devendra Gupta (India)
10.20 – 10.40 Endosurgery in case of massive tumors of thorax and abdomen – Alexander Razumovsky (Russia)
10.40 – 10.55 Neurosurgical management of medulloblastoma – the Hong Kong experience – Xian Lun Zhu (Hong Kong S.A.R.)
10.55 – 11.05 Surgical options in complex treatment of focal liver lesions in pediatric patients (144) – E. F. Kim, A. V. Filin, A. V. Semenkov, D. S. Burmistrov, O. V. Dimova, T. N. Galjan, E. U. Krjijanovskaia, A. V. Metelin, S. R. Varfolomeeva, D. U. Kachanov, T. V. Shamanskaja, R. A. Moiseenko, A. V. Petrushin (Russia)
11.05 – 11.15 Microsurgical reconstruction of maxilla and mandible in patients with head and neck tumors - pediatric experience (136) – Nikolay S. Grachev, Sergey V. Tereshuk, Natalia V. Babaskina, Igor N. Vorozhcov, Pavel D. Pryanikov, Margarita P. Kalinina (Russia)
11.15 – 11.25 Head and Neck Pediatric Oncologic Surgery in Cuba – Nelido Gonzalez Fernandez (Cuba)
11.25 – 11.30 Discussion
12.00 – 13.30 Plenary session: Optimization of care for children with haematological diseases and cancer. Improvement of multicentre collaboration.
Chairs: Veronika Skvortsova, Oleg Chestnov, Alexander Rumyantsev, Paul Rogers, Chi-Kong Li, Tezer Kutluk
12.00 – 12.15 Modern development of help for the patients with haematological and oncological diseases in the Russian Federation – Veronika Skvortsova (Russia)
12.15 – 12.30 WHO view on pediatric cancer – what’s next? – Oleg Chestnov (Switzerland)
12.30 – 12.45 Transferring of knowledges and organization of multicentre studies: SIOP experience – Paul Rogers (Canada)
12.45 – 13.00 Perspectives of multicentre collaboration in Asia on pediatric hematology/oncology – Chi Kong Li (Hong-Kong S.A.R.)
13.00 – 13.15 UICC experience in educational programms in LMICs – Tezer Kutluk (Turkey)
13.15 – 13.30 Childhood Leukemia and Population Health – What is Connection? – Eva Steliarova-Foucher (France)
14.30 – 16.00 Parallel Session: Histiocytosis/Acute Myeloid Leukemia
Chairs: Milen Minkov, Michael Maschan
14.30 – 14.50 Modern Strategies of Histiocytosis treatment – Milen Minkov (Austria)
14.50 – 15.05 Hemophagocytic Lymphohistiocytosis (HLH): Recent trends in diagnosis and Management – Bharat Agarwal (India)
15.05 – 15.15 Effectiveness, Toxicity and Place of Epigenetic Therapy in Childhood Acute Myeloid Leukemia (239) – Alexander Popa, Valentina Nemirovchenko, George Mentkevich (Russia)
15.15 – 15.25 Study of late effects and permanent consequences of pediatric onset Langerhans cell histiocytosis (343) – Gleb Bronin, Roman Miroshkin, Evgeniy Bezunov, Elizaveta Mironova, Elena Fisun, Yuliya Pashko, Bulat Kurmanov, Elena Promyslova, Lyudmila Sidorenko, Alexander Karelin, Vladimir Kasatkin, Nikolai Volodin (Russia)
15.25 – 15.35 Administrative aspects of the LCH-IV study – Elfriede Thiem (Austria)
15.35 – 15.45 High Level of miR-196b at Newly Diagnosed Pediatric Acute Myeloid Leukemia Predicts a Poor Outcome (262) - Li-hua XU, Qing YAN, Shaoyan Hu (China)
15.45 – 16.00 Discussion
14.30 – 16.00 Parallel session: Solid Tumours 1
Chairs: Torsten Simon, Denis Kachanov
14.30 – 14.40 Treatment of tumours of ovarian in children – Tezer Kutluk (Turkey)
14.40 – 14.50 Treatment of high-risk neuroblastoma: experience of Russian federal centers (251) - Denis Kachanov, Tatyana Shamanskaya, Evgeni Andreev, Sergey Talypov, Rimma Khismatullina, Denis Shevtsov, Elena Skorobogatova, Kirill Kirgizov, Lili Hachatryan, Vitaly Roschin, Yulia Olshanskaya (, Anna Kazakova, Elena Osipova, Elena Raykina, Elena Feoktistova, Alexey Shcherbakov, Galina Tereschenko, Alexey Nechesnyuk, Nikolay Grachev, Michael Maschan, Yury Likar, Svetlana Varfolomeeva (Russia)
14.50 – 15.00 Outcomes of children with Intermediate Risk Neuroblastoma: Experience from a tertiary cancer centre in India (226) – Monica Bhagat, Sajid S Qureshi (India)
15.00 – 15.10 Neuroblastoma with asymptomatic epidural extension: prolonged survival with palliative care (241) – Issarang Nuchprayoon (Thailand)
15.10 – 15.20 Expression of CD133, CD24 in Neuroblastoma and Prognostic Significance (122) – Qiang Zhao (China)
15.20 – 15.30 Outcome of Bones tumors in the childhood – Migdalia Perez Trejo (Cuba)
15.30 – 15.40 Multimodality Treatment Outcome of Hepatoblastoma: Our experience in a resource limited country (137) – ATM Atikur Rahman, Mehnaz Akter, Momena Begum, Chowdhury Shamsul Hoque Kibria, Afiqul Islam (Bangladesh)
15.40 – 15.50 Behaviorof Soft tissue sarcomas in the childhood in Cuba – Erasmo Gomez Cabrera (Cuba)
15.50 – 16.00 Discussion
16.30 – 18.30 Plenary session: Acute Myeloid Leukemia/Hematopoietic Stem Cell Transplantation
Chairs: Jeffrey Rubnitz, Boris Afanasiev, Alexey Maschan
16.30 – 16.50 Modern strategies in AML treatment – Jeffrey Rubnitz (USA)
16.50 – 17.10Modern strategies in HSCT at pediatric patients – Alejandro Madrigal (Great Britain)
17.10 – 17.30AML treatment: the Asian view – Daisuke Tomizawa (Japan)
17.30 – 17.50 Donor’s choice for HSCT and outcome – Boris Afanasiev (Russia)
17.50 – 18.10HSCT for AML at children: new strategies – Michael Maschan, Larisa Shelikhova, Alexey Maschan (Russia)
18.10 – 18.30 Discussion
8.00 – 9.45 Plenary session: Solid Tumours
Chairs: Akira Nakagawara, Carlos Rodriguez-Galindo
8.00 – 8.20 Modern neuroblastoma treatment strategies in Asia – Akira Nakagawara (Japan)
8.20 – 8.40 Update on sarcomas diagnosing and treatment – Carlos Rodriguez-Galindo (USA)
8.40 – 9.00 Neuroblastoma treatment options – individualized therapy – Torsten Simon (Germany)
9.00 – 9.20 Neurological signs of neuroblastoma – Kevin Rostasy (Germany)
9.20 – 9.40Actionable targets in neuroblastoma – Konstantin Dobrenkov (USA)
9.40 – 9.45 Discussion
10.00 – 11.30 Parallel session: Solid Tumours 2
Chairs: Purna Kurkure, Svetlana Varfolomeeva, Vladimir Polyakov
10.00 – 10.10 Intraarterial and intravitreal chemotherapy in the combined treatment in children with group C and D intraocular retinoblastoma (201) – Tatiana Ushakova, Olga Gorovtsova, Leonid Martynov, Nune Matinyan, Igor Trofimov, Andrey Yarovoy, Olga Krivovyaz, Svetlana Saakyan, Olga Ivanova, Boris Dolgushin, Vladimir Polyakov (Russia)
10.10 – 10.20 Neoadjuvant transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of clear cell sarcoma of the kidney (266) – Minju Li, Jinhu Wang, Daxing Tang, Shan Xu, Junqing Mao, Can Lai, Qiang Shu (China)
10.20 – 10.30 Childhood Non Rhabdomyosarcoma Soft Tissue Sarcomas Pattern and Outcome (340) – Mohamed Fawzy Hasan (Egypt)
10.30 – 10.40 Desmoplastic small round cell tumor in children and adolescents: single institution study (382) – Jung Yoon Choi, Hyoung Jin Lee, Che Ry Hong, Kyung Taek Hong, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin (South Korea)
10.40 – 10.50 Treatment of Wilms' tumour, a single institution experience (355) – Liudmila Shats, Margarita Belogurova (Russia)
10.50 – 11.00 Five Year Experience of Wilms Tumor at a tertiary care centre,where we stand?A developing country perspective (330) – Saadia Anwar, Mahwish Faizan, Safia Khan, Agha Shabbir Ali, Ahsan Waheed Rathore, Alia Ahmad, Mary Taj (Pakistan)
11.00 – 11.10 Monoclonal antibodies and vaccines for pediatric cancer treatment: New immunotherapies approach from Cuban biotechnology – Giselle Saurez Martinez (Cuba)
11.10 – 11.30 Discussion
10.00 – 11.30 Parallel Session: Bone Marrow Donor Registries «Europe-Asia-America»/HSCT
Chairs: Susanne Morsch, Kirill Kirgizov
10.00 – 10.15 European experience in Bone marrow donors search – Susanne Morsch (Germany)
10.15 – 10.30 NMDP experience in donor search and registry organization – Michael Boo (USA)
10.30 – 10.45 Donor registries – the Russian experience – Alexander Alyansky (Russia)
10.45 – 10.55 Survival and treatment of children with acute graft versus host disease: an 8-year single-сentre experience (225) – Andrey Kozlov, Tatyana Bykova, Julia Fedukova, Maxim Kucher, Elena Morozova, Elena Semenova, Anastasya Borovkova, Kirill Ekushov, Sergey Bondarenko, Olga Slesarchuk, Irina Kulagina, Babenko Elena, Alexander Alyansky, Maria Estrina, Lyudmila Zubarovskaya, Boris Afanasyev (Russia)
10.55 – 11.05 Experience of high-dose chemotherapy and autologous hematopoietic stem cell transplantation of pediatric patients with high risk rhabdomyosarcoma (094) – Seung Min Hahn, Won Kee Ahn, Ju Yeon Lim, Jung Woo Han, Moon Kyu Kim, Chuhl Joo Lyu (South Korea)
11.05 – 11.15 Functional activity of platelets and spatial thrombin generation after platelet concentrate transfusion in children after hematopoietic stem cell transplantation (195) - Ekaterina Koltsova, Anna Balandina, Irina Demina, Svetlana Radygina, Fazly Ataullakhanov, Dmitriy Balashov, Mikhail Panteleev (Russia)
11.15 – 11.30 Discussion
12.30 – 14.00 Parallelsession: Lymphomas
Chairs: Ilske Osсhlies, Margarita Belogurova
12.30 – 12.45 Modern approaches in lymphoma diagnosing – Ilske Osсhlies (Germany)
12.45 – 13.00 Lymphoma in children – Eiichi Ishii (Japan)
13.00 – 13.15 Multicentre Collaboration on childhood lymphoma:report from CCCG Lymphoma Study Group – Yijin Gao (China)
13.15 – 13.25 Experience of treatment with the protocol with reduced intensity – Elena Samochatova, Natalia Myakova (Russia)
13.25 – 13.35 Clinical Profile and prognostic factors in children with sporadic Burkitt’s Lymphoma: An Indian experience (290) – Smitha Hv, Nita Radhakrishnan, Veronique Dinand, Anupam Sachdeva (India)
13.35 – 13.45 Strategy of Treatment Children with Relapse/Refractory Hodgkin’s Lymphoma (302) – Natalia Kulichkina, Elena Belyaeva, George Mentkevich, Alexander Popa (Russia)
13.45 –14.00 Discussion
12.30 – 14.00 Parallel Session: Non-malignant haematology
Chairs: Dzavid Gaziev, Anna Scherbina
12.30 – 12.45 Thalassemia treatment options – Dzhavid Gaziev (Italy)
12.45 – 13.00 Modern treatment approaches to aplastic anemia at children – Galina Novichkova (Russia)
13.00 – 13.15 Upfront alternate donor HSCT for children with severe aplastic anemia – Jing Chen (China)
13.15 – 13.30 Neutropenic syndromes: modern diagnosing and treatment strategies – Anna Scherbina (Russia)
13.30 – 13.40 Serum interleukin-10 level in childhood immune thrombocytopenia and its role in predicting the clinical course – a prospective case control study (245) – Vinod Gunasekaran, Nita Radhakrishnan, Veronique Dinand, Anupam Sachdeva (India)
13.40 – 13.50 HSCT for patients with non-malignant diseases – Dmitry Balashov (Russia)
13.50 – 14.00 Phenotypic variability in ELANE–related neutropenia from mutated Ala57 residue (358) – Chang-Hun Park, Silvia Park, Yae-Jean Kim, Sun-Hee Kim, Hee-Jin Kim (South Korea)
14.30 – 16.00 Plenary session: CNS Tumours
Chairs: Michael Kam, Pablo Hernaiz
14.30 – 14.50 Low grade gliomas and modern strategy of diagnostics approach and treatment – Pablo Hernaiz (Germany)
14.50 – 15.10 CNS Germ Cell Tumours – Michael Kam (Hong-Kong S.A.R.)
15.10 – 15.25 Modern approaches in CNS tumours treatment – Jun-ichi Hara (Japan)
15.25 – 15.35 Nimotuzumab a novel anti-EGFR monoclonal antibody in pediatric brain tumors. Where are the opportunities? – Giselle Saurez Martinez (Cuba)
15.35 – 15.45 Review on the Management & Outcome of Childhood Cerebral or Cerebellar Low Grade Glioma (276) – Godfrey Chi-Fung Chan, Matthew Ming-Kong Shing, Kai-On Chang, Dennis Tak-Noi Ku, Alvin Siu-Cheung Ling, Anthony Pak-Yin Liu (Hong Kong S.A.R.)
15.45 – 15.55 Preliminary results of treatment according to HIT-MED-Study Guideline 2014 in Russian cohort of patients (298) – Ella Kumirova, Sergey Ozerov, Ludmila Papusha, Ekaterina Salnikova, Irina Borodina, Alexey Samarin, Victoria Yemtsova, Anastasia Ektova, Alexey Kislyakov, Marina Ryzhova, Agnessa Panfyorova, Alexey Nechesnyuk, Darya Kobyzeva, Anastasia Usychkina, Anton Artemov, Ludmila Zemtsova, Anna Kazakova, Svetlana Homyakova, Maria Dubrovina, Alexey Pshonkin, Marina Tihonova, Alen Spirin, Sergei Gorelishev, Egor Shorikov, Inna Gerbek, Alexander Shapochnik, Margarita Belogurova, Galina Novichkova, Alexander Karachunskiy, Andge Valiakhmetova, Mikle Andrianov, Galina Tereschenko (Russia)
15.55 – 16.00 Discussion
16.30 – 18.00 Parallel session: Supporting therapy/Infection control
Chairs: Bharat Agarwal, Galina Novichkova
16.30 – 16.40 Positive impact of the protocols of empirical anti-infective therapy on the drug resistance index and pharmacoeconomics (308) – Valentina Pirumova, Galina Solopova (Russia)
16.40 – 16.50 Risk Prediction of Fever in Neutropenic Children with Acute Lymphoblastic Leukemia (269) - Lutfor Rahman Molla, Chowdhury Yakub Jamal, Momena Begum, Mehnaz Akter, Md. Bani Yeamin, Md Tanvir Ahammed, S M Rezanur Rahman, Zannat Ara, Rasel Siddique (Bangladesh)
16.50 – 17.00 Invasive fungal diseases in adolescents and young adults after allogeneic hematopoietic stem cell transplantation (227) – Marina Olegovna Popova, Alisa Volkova, Ayzsilnieks Oksana, Olga Pinegina, Svetlana Ignatyeva, Kirill Ekushev, Olga Slesarchuk, Maria Vladovskaya, Ludmila Stepanovna Zubarovskaya, Nikolay Nikolaevich Klimko, Boris Vladimirovich Afanasyev (Russia).
17.00 – 17.10 Incidence and clinical spectrum of drug resistant bacterial infections and associated mortality in pediatric hemato-oncology: experience from a tertiary care centre in South India (314) – Atish Narayanrao Bakane, Revathi R Raj, Sreejith R Kurup, Ramya S Uppuluri, Divya S Subburaj (India)
17.10 – 17.20 The results of serologic and bacteriologic examinations of bronchoalveolar lavage for fungal infection in immunocompromised patients (286) – Sviatlana Kandaurava, Olga Aleinikova (Belarus)
17.20 – 17.30 Evaluation of Chemotherapy-Induced Oral Mucositis in Pediatric Oncology Hospital (363) – Sarah Mohamed Abdelsamie, Mohamed Abdelrahman, Doaa Abdelmegeed (Egypt)
17.30 – 17.40 Placement of the ommaya reservoir in narrow and slit-like ventricles using a neuronavigation system (127) – Sergey Ozerov, Alexey Samarin, Andrey Melnikov, Ella Kumirova (Russia)
17.40 – 18.00 Discussion
16.30 – 18.00 Parallel Session: Surgery 2
Chairs: Devendra Gupta, Alexander Razumovsky
16.30 – 16.45 The role of surgery in oncologic pediatric patients – Zacharias Zachariou (Cyprus)
16.45 – 17.00 International collaboration in pediatric oncological surgery – Chan Hon Chui (Singapore)
17.00 – 17.10 Modern strategy of pediatric abdominal surgery – Andrey Ryabov (Russia)
17.10 – 17.20 Current Surgical Strategy for Neuroblastoma – Akihiro Yoneda (Japan)
17.20 – 17.30 Treatment outcome of retinoblastoma with combined systemic, intra-arterial, and intravitreal chemotherapy: a single center experience (220) –
Won kee Ahn, Seung Min Hahn, Ju Yeon Lim,Jung Woo Han, Dong Joon Kim, Sung Chul Lee, Chuhl Joo Lyu (South Korea)
17.30 – 17.40 Summing up the Results of endoprothesis for children with bone sarcomas: the East-European Sarcoma Group (EESG) (404) – Dmitry Nisichenko, Aslan Dzampaev, Maxim Kubirov, Denis Hestanov, Mamed Aliev (Russia)
17.40 – 17.50 Pediatric oncologic crisis: a challenging brawl! – Shilpa Sharma, Devendra K Gupta (India)
17.50 – 18.00 Discussion
8.00 – 10.00 Plenary Session:Late effects. Survivors.
Chairs: Chi-Kong Li, Benson Pau
JOINT SESSION: SIOP and CCI
Participants: Physicians, Nurses, CCI-members
9.00 – 9.10 Opening remarks – Chi-Kong Li, Benson Pau
9.10 – 9.30 Late effects in pediatric cancer survivors – Melissa Hudson (USA)
9.30 – 9.40 Psychological aspects in pediatric oncology – Martha Grootenhuis (Netherlands)
9.40 – 9.50 Treatment Abandon: Causes & Solutions – Bharat Agarwal (India)
9.50 – 10.00 Late effects in pediatric oncology – Purna Kurkure (India)
10.10 – 10.20 Quality of life in pediatric hematooncological patients – Shulamit Kreitler (Israel)
10.20 – 10.30 Cancer Survivors: how can we help? – Poonam Bagai (India)
10.30 – 10.40 Psychology in pediatric hematology-oncology: modern aspects – Alina Khain (Russia)
10.40 – 11.00 Survivors
10.30 – 11.30 Special Session: Best Poster oral presentations.
Chairs: Chi-Kong Li, Alexander Rumyantsev, Svetlana Varfolomeeva
10.30 – 11.20 9 Best Poster winners oral presentations (5 min. each)
11.20 – 11.30 Discussion
12.00 – 13.30 Parallel Session: Modern diagnosing and treatment approach
Chairs: Tezer Kutluk, Alexander Rumyantsev
12.00 – 12.10 Survey on Pediatric Cancer Patients in Kanto-Koshinetsu Area after the Election of Childhood Cancer Core Hospitals in Japan (238) – Kimikazu Matsumoto, Yuki Yuza, Hiroaki Goto, Katsuyoshi Ko, Daisuke Tomizawa, Takashi Kaneko (Japan)
12.10 – 12.20 V(D)J recombination excision circles as markers of T- and B-cell immune reconstitution in patients with acute lymphoblastic leukaemia (123) – Igor V. Obraztsov, Maria A. Gordukova, Ekaterina V. Tsvetkova, Elena V. Kononova, Ivan Y. Tomilin, Andrey P. Prodeus, Alexander G. Rumyantsev (Russia)
12.20 – 12.30 Stromal Collagen type XI Alpha 1 COL11A1 expression in Neuroblastoma (089) – Chi Bao Bui, Hieu Kim Huynh, My Diem Vu, Dinh Khai Truong, Tan Son Vo (Vietnam)
12.30 – 12.40 Relationship between spontaneous and post treatment apoptotic index and apoptotic proteins to prednisolone response and post induction minimal residual disease (MRD) status in pediatric acute lymphoblastic leukemia (ALL) (063) – Bhatia Prateek, Singh Ankita, Trehan Amita, Bansal Deepak, Bhatia Alka, Singh Sachdeva, Man Updesh, Jain Richa (India)
12.40 – 12.50 Rare pediatric renal tumors: always keep in mind. An experience of one laboratory (295) – Anna Mitrofanova, Dmitry Konovalov (Russia)
12.50 – 13.00 Segmental chromosomal alterations have prognostic impact in primary and relapsed neuroblastoma patients (082) – Alexander Druy, Egor Shorikov, Grigory Tsaur, Leonid Saveliev, Larisa Fechina (Russia)
13.00 – 13.10 The efficacy of cyclosporin in the treatment of infant case with subcutaneous panniculitis-like T-cell lymphoma (099) – Michihiro Yano, Miwa Hebigughi, Koya Kodama, Tsutomu Takahashi (Japan)
13.10 – 13.20 Testing of cognitive and emotional behaviour disturbancies in children with ALL (154) – Vladimir Kasatkin (Russia)
13.20 – 13.30 Discussion
12.00 – 13.30 Parallel Session: Radiotherapy
Chairs: Hideyuki Sakurai, Miwako Nozaki
12.00 – 12.15 Proton beam therapy for pediatric cancer in Japan – Hideyuki Sakurai (Japan)
12.15 – 12.30 The role of radiation therapy for pediatric renal tumor – Miwako Nozaki (Japan)
12.30 – 12.40 First Russian experience in Tomotherapy application for total body irradiation for children (139) – Darya Kobizeva, Alexey Nechesnyuk (Russia)
12.40 – 12.50 An effective stereotactic radiotherapy for recurrent pilomyxoid astrocytoma in the medulla oblongata of pediatric patient (169) – Tamami Yano, Michihiro Yano, Miwa Hebiguchi, Koya Kodama, Tsutomu Takahashi (Japan)
12.50 – 13.00 The role of adjuvant chemotherapy for radiation therapy of diffusely growing tumors of the brain stem in children (148) – Oleg Shcherbenko, Roman Parhomenko, Natalij Zelinskaj, Fedor Antonenko (Russia)
13.00 – 13.10 Interstitial Brachytherapy For Childhood Soft Tissue Sarcomas: Long Term Disease Outcome & Late Effects (292) – Siddhartha Laskar, Nehal Khanna, Ajay Puri, Sajid Qureshi, Ashish Gulia, Tushar Vora, Bharat Rekhi, Seema Media, Girish Chinnaswamy, Shashikant Juvekar, Subhash Desai, Yogesh Ghadi (India)
13.10 – 13.20Radiation Therapy and Nimotuzumab inChildren and Adolescents with Brainstem Gliomas: A 5-Year Institutional Experience (378) - Migdalia Perez, Jose Alert, Jesus Reno, Mariuska Forteza (Cuba)
13.20 – 13.30 Discussion
12.00 – 13.30 Parallel Session: Psychology and palliative care aspects in pediatric oncology
Chairs: Martha Grootenhuis, Alina Khain
12.00 – 12.20 Disparities in the Global Landscape of Palliative Care Clinical Trials (352) – Catherine Lam, Scott Howard (USA)
12.20 – 12.30 Indicators of the Russian infrastructure of inpatient pediatric palliative care with malignancies (288) – Diana Nevzorova, Elena Polevichenko, Lyudmila Kochetkova (Russia)
12.30 – 12.40 The stigma of cancer in developing countries - Atish Narayanrao Bakane, Ramya S Uppuluri, Divya S Subburaj, Sreejith R Kurup, Revathi R Raj (India)
12.40 – 12.50 Evaluation of Burnout Syndrome in Pediatric Hematologists/Oncologists (270) – Tatiana Stepanova, Galina Trubnikova, Irina Balalaeva, Natalia Yudina (Russia)
12.50 – 13.00 Reproductive behavior of the families with children-cancer survivors (280) – Marina Alexandrovna Guseva, Grigory Yankelevich Tseitlin, Anatoly Ivanovich Antonov (Russia)
13.00 – 13.10 Subculture groups of children in medical institution in aspect of interaction with parents communities and public organizations (397) – Irina Ageeva-Podobed, Galina Kireeva (Russia)
13.10 – 13.20 Social isolation as a long-term psychological side effect of bone marrow transplantation in children (173) –Svetlana Oleshko, Olga Chernenko, Olga Ushakova, Dmitrii Bakun, Yuliya Fediukova, Anastasiya Borovkova, Polina Kozhokar, Olesya Paina, Kirill Ekushev, Ludmila Zubarovskaya, Boris Afanasyev (Russia)
13.20 – 13.30 Discussion
14.00 – 15.00 Plenary Session: Modern diagnosing and treatment approach
Chairs: Chi-Kong Li, Alexander Rumyantsev
Panel discussion:
14.00 – 14.05 Chi-Kong Li
14.05 – 14.10 Alexander Rumayntsev
14.10 – 14.15 Paul Rogers
14.15 – 14.20 Tezer Kutluk
14.20 – 14.40 Open discussion
14.40 – 15.00 Chair's remarks
15.30 – 16.00 Closing Ceremony
15.30 – 15.35 Farewell words – Chi-Kong Li
15.35 – 15.40 Presentation of SIOP Asia Congress 2017
15.40 – 15.45 Farewell words – Alexander Rumyantsev
15.45 – 16.00 Small closing performance